Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Health Investors (NHI)

NHI signs change-in-control severance agreements with five named executive officers

Neutral Impact 2 of 5 leadership Written later

On December 15, 2025, National Health Investors entered into updated change-in-control severance agreements with five named executive officers, replacing agreements dated February 26, 2024. The agreements set cash severance multiples, COBRA coverage and equity vesting if an executive is terminated without cause or resigns for good reason within two years after a change in control.

Key points

  • Agreements dated December 15, 2025 cover D. Eric Mendelsohn, Kristin S. Gaines, Kevin C. Pascoe, John L. Spaid and David L. Travis
  • Lump sum severance multiples are 3.0 times for Mendelsohn, 2.0 times for Pascoe and Spaid, and 1.5 times for Gaines and Travis
  • Benefits include 18 months of COBRA coverage and accelerated vesting of time-based equity awards

The filing

CompanyNational Health Investors (NHI)
Form8-K, current report
Filed with the SECDec 18, 2025, 6:01 PM ET
Accession number0000877860-25-000198

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:39 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 18, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.